This study aimed to investigate GSDMD gene expression in bladder cancer tissue samples in comparison to control samples to assess its potential role in pathogenesis and aggressiveness of bladder cancer, thus the role of GSDMD as a new possible target for management of bladder cancer. This evidence concerns the gene GSDMD and urinary bladder carcinoma.